课题基金 / 基金详情

Uncovering novel regulators of splenic hematopoiesis during cardiovascular disease

Uncovering novel regulators of splenic hematopoiesis during cardiovascular disease
发现心血管疾病期间脾造血的新调节因子
批准号:
473770
负责人:
Rasheed Adil
金额:
$3.28万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-10-01 至 2023-10-01

项目摘要

项目成果

Rasheed Adil的其他基金

相似基金

相关文献

中文摘要
翻译
在西方社会,心脏病是导致死亡的最大原因,其特点是血液中胆固醇升高和心脏炎症。动脉粥样硬化是心脏病的一种并发症,被认为是心脏血管狭窄
英文摘要
Heart disease is the greatest contributor to death in Western society and is characterized by increased blood cholesterol and inflammation in the heart. Atherosclerosis, a complication of heart disease, is recognized as a narrowing of vessels in the heart
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyperlipidemia-induced Hematopoiesis is Repressed by MLKL in Endothelial Cells of the Splenic Niche
Knockdown of the Mixed Lineage Kinase Domain-Like Protein (MLKL) Enhances Extramedullary Hematopoiesis to Increase Atherosclerosis
海外基金